MedPath

Does Gender Play a Role in Bone-mineral Density Measurement Precision?

Completed
Conditions
Osteoporosis
Registration Number
NCT01324713
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

Bone mineral density (BMD) measurement using dual-energy x-ray absorptiometry (DXA) is the current gold standard for osteoporosis diagnosis and therapy monitoring. Like all quantitative tests, there is some variability in BMD results obtained when scanning a person more than once. As such, it is current clinical practice, based on the recommendation of the International Society for Clinical Densitometry, that each technologist perform a precision assessment. This approach consists of scanning 30 people twice; the data from which allow determination of what constitutes a real difference in BMD with 95% confidence. A precision assessment typically evaluates a specific clinic's population, using the age range and genders seen at that clinic. However men generally have larger, but often more arthritic, bones than women which may impact the precision results. Therefore, it is possible that gender-specific precision values should be used in clinical practice, however this issue has never been investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Age ≥ 65 years
  • Able and willing to sign informed consent
Exclusion Criteria
  • Inability to have DXA scans performed due to weight ≥ 450 pounds (exceeds densitometer table limit)
  • Metallic hardware in, or overlaying, any of the measured skeletal sites

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DXA Bone Mineral Density precision1 day

The primary analysis will compare DXA BMD precision (mean square error/variance) in males and females, pooled across technicians, using the two-sample F-test for equality of variances. Separate analyses will also be performed for each technician. In addition, due to the sensitivity of the F-test to the normality assumption, a secondary analysis will perform the same comparisons using Levene's test. A nominal two-sided p-value of 0.05 will be regarded as statistically significant.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin Osteoporosis Clinical Center and Research Program

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath